KLI
JNJ icon

Kelman-Lazarov Inc’s Johnson & Johnson JNJ Stock Holding History

Kelman-Lazarov Inc’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$896K Buy
3,664
+381
+12% +$88.7K 0.13% 66
2025
Q4 		$680K Buy
3,283
+31
+1% +$6.13K 0.1% 80
2025
Q3 		$603K Buy
3,252
+362
+13% +$62K 0.09% 82
2025
Q2 		$442K Sell
2,890
-1,080
-27% -$166K 0.07% 82
2025
Q1 		$658K Buy
3,970
+19
+0.5% +$2.97K 0.12% 65
2024
Q4 		$571K Sell
3,951
-195
-5% -$30.2K 0.1% 67
2024
Q3 		$672K Sell
4,146
-29
-0.7% -$4.62K 0.12% 62
2024
Q2 		$610K Sell
4,175
-83
-2% -$12.3K 0.11% 63
2024
Q1 		$674K Buy
4,258
+14
+0.3% +$2.23K 0.13% 58
2023
Q4 		$665K Sell
4,244
-165
-4% -$25.3K 0.14% 55
2023
Q3 		$687K Buy
4,409
+284
+7% +$46.9K 0.16% 52
2023
Q2 		$683K Buy
4,125
+151
+4% +$24.4K 0.16% 52
2023
Q1 		$616K Buy
3,974
+21
+0.5% +$3.39K 0.16% 53
2022
Q4 		$698K Sell
3,953
-395
-9% -$68.2K 0.2% 50
2022
Q3 		$710K Buy
4,348
+200
+5% +$33.8K 0.24% 36
2022
Q2 		$736K Sell
4,148
-224
-5% -$39.9K 0.25% 35
2022
Q1 		$775K Sell
4,372
-50
-1% -$8.51K 0.26% 35
2021
Q4 		$756K Buy
4,422
+329
+8% +$53.9K 0.24% 40
2021
Q3 		$661K Sell
4,093
-155
-4% -$26.4K 0.23% 41
2021
Q2 		$700K Sell
4,248
-230
-5% -$38.1K 0.24% 40
2021
Q1 		$736K Hold
4,478
– – 0.26% 36
2020
Q4 		$705K Buy
4,478
+50
+1% +$7.38K 0.27% 38
2020
Q3 		$659K Buy
4,428
+218
+5% +$32.3K 0.3% 37
2020
Q2 		$592K Sell
4,210
-409
-9% -$59.6K 0.27% 38
2020
Q1 		$606K Sell
4,619
-170
-4% -$24.1K 0.32% 38
2019
Q4 		$699K Sell
4,789
-86
-2% -$11.7K 0.31% 47
2019
Q3 		$631K Sell
4,875
-168
-3% -$22.1K 0.31% 46
2019
Q2 		$702K Hold
5,043
– – 0.36% 47
2019
Q1 		$705K Buy
5,043
+562
+13% +$75.3K 0.37% 47
2018
Q4 		$578K Hold
4,481
– – 0.36% 57
2018
Q3 		$619K Sell
4,481
-200
-4% -$26.6K 0.36% 60
2018
Q2 		$568K Sell
4,681
-191
-4% -$23.8K 0.3% 72
2018
Q1 		$624K Sell
4,872
-200
-4% -$27K 0.34% 70
2017
Q4 		$709K Sell
5,072
-150
-3% -$20.9K 0.36% 65
2017
Q3 		$679K Sell
5,222
-2,247
-30% -$298K 0.36% 70
2017
Q2 		$988K Buy
7,469
+200
+3% +$25.5K 0.54% 58
2017
Q1 		$905K Sell
7,269
-50
-0.7% -$5.97K 0.58% 54
2016
Q4 		$843K Sell
7,319
-656
-8% -$75.8K 0.48% 60
2016
Q3 		$948K Sell
7,975
-674
-8% -$81.8K 0.54% 54
2016
Q2 		$1.05M Sell
8,649
-101
-1% -$11.5K 0.6% 53
2016
Q1 		$955K Buy
+8,750
New +$906K 0.56% 53

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kelman-Lazarov Inc's JNJ Position: Q1 2026 in Review

Kelman-Lazarov Inc increased its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, buying an estimated $88.7K and bringing the position to 3,664 shares worth $896K. The position accounts for 0.13% of the portfolio, ranked #66.

Kelman-Lazarov Inc first reported a position in JNJ in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.05M in Q2 2016. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Kelman-Lazarov Inc held 3,664 shares of Johnson & Johnson worth $896K as of Q1 2026.
  • Kelman-Lazarov Inc bought 381 Johnson & Johnson shares in Q1 2026, an estimated $88.7K.
  • Johnson & Johnson made up 0.13% of Kelman-Lazarov Inc's portfolio in Q1 2026, its #66 holding.
  • Kelman-Lazarov Inc first reported a position in Johnson & Johnson in Q1 2016 and has held it in 41 quarters since.
  • Kelman-Lazarov Inc's Johnson & Johnson position peaked at $1.05M in Q2 2016.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Kelman-Lazarov Inc's 13F filing for Q1 2026, filed 27 Apr 2026.